Searchable abstracts of presentations at key conferences in endocrinology

ea0070ep208 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Lateral thinking in new onset diabetes

Htet Aung Htet , Yin Yin , Kaplan Felicity , Hayes Aimee

A 54-year-old gentleman presented to his GP in July 2019 with significant weight loss, polyuria and nocturia for two to three months. His HbA1c was 78 mmol/mol. He was diagnosed with diabetes and started on Metformin 500 mg BD. Upon consultant review in September 2019, he reported a 26 kg weight loss over the preceding four years, much of which was apparently intentional, and right abdominal discomfort. His paternal grandmother died of pancreatic cancer, as did his paternal au...

ea0087p14 | Poster Presentations | UKINETS2022

Somatostatin receptors in olfactory neuroblastoma: The rationale for peptide receptor radionuclide therapy

Porto Juliana , Hayes Aimee , Branton Alexander , Caplin Martyn , Alusi Martyn , Grossman Ashley

Olfactory neuroblastoma (ONB) is a rare neuroendocrine tumour with a slow onset of symptoms, and classically a propensity for recurrence and a poor prognosis. Due to its rarity, there is no agreed standard therapy, but treatment will usually include surgical resection, adjuvant radiotherapy and/or chemotherapy. However, such tumours very often show positive uptake on somatostatin receptor radionuclide scanning, and selective use of peptide receptor radionuclide therapy (PRRT) ...

ea0077p214 | Neuroendocrinology and Pituitary | SFEBES2021

Pregnancy and neuroendocrine neoplasms

Ratnayake Gowri M , Armonis Panagiotis , Hayes Aimee R , Mandair Dalvinder , Khoo Bernard , Toumpanakis Christos , Grossman Ashley B , Caplin Martyn E

Background: The incidence of neuroendocrine neoplasms (NENs) in younger populations (<50 years) is increasing and was 1.8 per 100,000 persons in 2011. There is limited data on NENs and pregnancy.Methods: A retrospective analysis was performed on pregnant women with NENs managed in an ENETS Centre of Excellence. The objectives of the study were to describe the tumour characteristics, pregnancy outcomes, treatment and the tumour behaviour intra-pregnan...

ea0090p141 | Pituitary and Neuroendocrinology | ECE2023

177Lu DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) in advanced Phaeochromocytomas and paragangliomas (PPGL) – a single centre experience at a ENETS Centre of Excellence

Mansukhbhai Shekhda Kalyan , Armeni Eleni , Hayes Aimee , Caplin Martyn , Toumpanakis Christos , Mandair Dalvinder , Quigley Ann-Marie , Navalkissoor Shaunak , Grossman Ashley , Khoo Bernard

Introduction: Phaeochromocytomas and paragangliomas (PPGL) are rare neuroendocrine tumours with no standardised protocol for treatment. 177Lu-DOTATATE peptide receptor radionuclide therapy (PRRT) is an emerging treatment option for patients with metastatic and/or inoperable PPGL, and with low toxicity. We present our experience with PRRT in advanced PPGL, treated in a ENETS Centre of Excellence.Materials and Methods: 165 patients with...

ea0060p24 | (1) | UKINETS2018

Assessment of fat-soluble vitamins and trace elements in neuroendocrine tumour (NET) patients on somatostatin analogues

Ewang-Emukowhate Mfon , Whyand Tara , Chotai De Lima Yasmin , Toumpanakis Christos , Mandair Dalvinder , Hayes Aimee , Grossman Ashley , Nair Devaki , Caplin Martyn

Introduction: NETs are a diverse group of neoplasms that originate from cells of the diffuse endocrine system. Often somatostatin analogues (SSA) are used as a first line treatment. Loose stools and steatorrhea are common adverse effects of SSA. This can affect the absorption of fat soluble vitamins and trace elements (TE). In this study we assess the prevalence of these deficiencies.Methods: A prospective study of 66 patients on SSA. Vitamins A,D,E,K an...

ea0094oc2.2 | Endocrine Cancer and Late Effects | SFEBES2023

177Lu-DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) in Metastatic/inoperable phaeochromocytomas and paragangliomas and focus on the impact of genetic variations in SDHx mutation on treatment outcomes – A single centre retrospective analysis of experience at an ENETS Centre of Excellence

Mansukhbhai Shekhda Kalyan , Armeni Eleni , Hayes Aimee , Navalkissoor Shaunak , Mandair Dalvinder , Xu Yiwang , Yu Dominic , Quigley Ann-Marie , Gnanasegaran Gopinath , Toumpanakis Christos , Caplin Martyn , Khoo Bernard

Introduction: Metastatic phaeochromocytomas (PCC) and paragangliomas (PGL), collectively known as metastatic PPGL (mPPGL), represent uncommon neuroendocrine tumours for which no standardized treatment guidelines exist. The emerging therapeutic modality employing 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) has exhibited favourable tolerability in the management of these patients.Methods: In this...

ea0096p5 | Section | UKINETS2023

Investigation of the utility of [68Ga]Ga-DOTA-TATE PET/CT scanning in patients with Multiple Endocrine Neoplasia Type 1 (MEN1) with suspected pancreatic neuroendocrine tumours

Kalyan Vamshi Vemulapalli Dr , Gnanasegaran Dr. Gopinath , Ratnayake Dr. Gowri , Ashley Grossman Professor , Hayes Dr. Aimee , Khoo Dr. Bernard , Martyn Caplin Professor , Navalkissoor Dr. Shaunak

Purpose: To evaluate the added benefit and accuracy of [68Ga]Ga-DOTA-TATE PET/CT scans in detecting pancreatic neuroendocrine tumours, compared to conventional cross-sectional imaging with CT or MRI scans, in patients with multiple endocrine neoplasia type 1 (MEN1)Methods: A retrospective analysis was performed comparing the initial [68Ga]Ga-DOTA-TATE PET/CT to the respective contemporary CT or MRI ...

ea0021sig1.2 | Andrology Special Interest Group Session | SFEBES2009

Testosterone deficiency in metabolic syndrome

Hayes F

Epidemiologic studies have associated low testosterone levels with increased cardiovascular mortality in men, the mechanism of which is unclear. However, low testosterone levels have been linked to the development of cardiovascular risk factors including metabolic syndrome, regardless of the definition employed. This relationship has been observed in epidemiologic studies of community-dwelling men as well as in men with prostate cancer treated with androgen-deprivation therapy...

ea0056p432 | Diabetes complications | ECE2018

Association of adverse pregnancy outcomes with glycemic cut-offs stated by the IADPSG, POGS and WHO diagnostic criteria for gestational diabetes mellitus in De La Salle University Medical Center (DLSUMC), Cavite, Philippines from January 2012 to December 2015

Francisco Danica , Andag-Silva Aimee

Objectives: To determine the association between adverse pregnancy outcomes with each of the 75 g OGTT cut-off values prescribed by the World Health Organization (WHO), Philippine Obstetrical and Gynecological Society (POGS), and the International Association of Diabetes in Pregnancy Study group (IASDPG) criteria to help define more appropriate glycemic cut-off levels for Filipinas.Methodology: Retrospective Cohort study of pregnancy deliveries in De La ...

ea0007p144 | Growth and development | BES2004

Gene expression in peripheral blood mononuclear cells: the effect of GH in a GH-deficient child

Whatmore A , Hayes A , Patel L , Clayton P

Gene arrays are a powerful tool to search for novel targets of drug action and disease-specific patterns of gene expression. GH has pleiotropic actions and thus a wide range of potential gene targets. Using an accessible tissue, namely peripheral blood mononuclear cells (PBMNCs), we have started to explore the use of gene arrays in the context of the in-vivo response to GH treatment.PBMNCs were obtained with consent and ethical permission from 2 prepuber...